Rac1 gene mutations in human brain tumours

European Journal of Surgical Oncology

Volumn 30, Issue 1, 2004, Pages 68-72

  Hwang, S L ^a   Hong, Y R ^b   Sy, W D ^b   Lieu, A S ^a   Lin, C L ^a   Lee, K S ^a   Howng, S L ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Brain tumours; Rac1

Indexed keywords

RAC1 PROTEIN;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HYPOPHYSIS ADENOMA; MENINGIOMA; MOLECULAR CLONING; NEURILEMOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEQUENCE ANALYSIS; TUMOR CLASSIFICATION;

EID: 0842280665     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.10.018     Document Type: Article

References (32)

1. Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R. Rac, a novel ras-related family of proteins that are botulinum toxin substrates. J Biol Chem 1989;264: 16378-16382.
2. Shirsat NV, Pignolo RJ, Kreider BL, Rovera G. A member of the ras gene superfamily is expressed specifically in T, B and myeloid hemopoietic cells. Oncogene 1990;5:769-772.
3. Ridley AJ, Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 1992;70:389-399.
4. Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 1992;70:401-410.
5. Westwick JK, Lambert QT, Clark GJ, Symons M, Van Aelst L, Pestell RG et al. Rac regulation of transformation, gene expression, actin organization by multiple, PAK-independent pathways. Mol Cell Biol 1997;17:1324-1335.
6. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N et al. The small GTP-binding protein Rac1 and Cdc42 regulated the activity of the JNK/SAPK signaling pathway. Cell 1995;81:1137-1146.
7. Minden A, Lin A, Claret FX, Abo A, Karin M. Selective of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc 42Hs. Cell 1995;81: 1147-1157.
8. Olson MF, Ashworth A, Hall A. An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1. Science 1995;269:1270-1272.
9. Qiu RG, Chen J, Kirn D, McCormick F, Symons M. An essential role for Rac in Ras transformation. Nature 1995;374: 457-459.
10. Khosravi-Far R, Solski PA, Clark GJ, Kinch MS, Der CJ. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation. Mol Cell Biol 1995;15:6443-6453.
11. Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz PF, Der CJ. Critical role of RhoB in cell transformation by oncogenic Ras. Oncogene 1995;10:2289-2296.
12. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997;275:1649-1652.
13. Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JG. A role for Rac in Tiaml-induced membrane ruffling and invasion. Nature 1995;375:338-340.
14. Schmitz A, Govek E, Bottner B, Van Aelst L. Rho GTPases: signaling, migration and invasion. Exp Cell Res 2000;261: 1-12.
15. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA, Collard JG. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 2000;36: 1269-1274.
16. Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J et al. Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-Kappa B-dependent pathway. J Biol Chem 1999;274:25245-25249.
17. Jaffe A, Hall A. Rho GTPases in transformation and metastasis. Adv Cancer Res 2002;65:57-79.
18. Arato-Ohshima T, Sawa H. Overexpression of cyclin D1 induces glioma invasion by increasing matrix metalloproteinase activity and cell motility. Int J Cancer 1999;83: 387-392.
19. Senger DL, Tudan C, Guiot MC, Mazzoni IE, Molenkamp G, LeBlanc R, Antel J, Olivier A, Snipes GJ, Kaplan DR. Suppression of Rac activity induces apoptosis of human glioma cells but not normal human astrocytes. Cancer Res 2002;62:2131-2140.
20. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
21. Prives C, Manfredi JJ. The p53 tumor suppressor protein: meeting review. Genes Dev 1993;7:529-534.
22. Marshall MS. The effector interactions of p21 ras. Trends Biochem Sci 1993;18:250-254.
23. Freeman JLR, Kreck ML, Uhlinger DJ, Lambeth JD. Ras effector-homologue region on Rac regulates protein associations in the neutrophil respiratory burst oxidase complex. Biochemistry 1994;33:13431-13435.
24. Freeman JLR, Lambeth JD. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem 1996;271: 22578-22582.
25. Garrett MD, Self AJ, van Oers C, Hall A. Identification of distinct cytoplasmic targets for ras/R-ras and rho regulatory proteins. J Biol Chem 1989;264:10-13.
26. Settleman J, Albright CF, Foster LC, Weinberg RA. Association between GTPase activator for Rho and Ras families. Nature 1992;359:153-154.
27. Xu X, Barry DC, Settleman J, Schwartz MA, Bokoch GM. Differing structural requirements for GTPase-activating protein responsiveness and NADPH oxidase activation by Rac. J Biol Chem 1994;269:23569-23574.
28. Soon LL, Yie TA, Shvarts A, Levine AJ, Su F, Tchou-Wong KM. Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem 2003;278:11465-11470.
29. Hwang SL, Howng SL. Atypical and malignant meningioma-report of five cases and review of literature. Acta Neurol Sin 1993;2:47-52.
30. Okazaki H, Scheithauer BW. Atlas of neuropathology. Philadelphia: Lippincott, 1988.
31. Lang FF, Miller DC, Koslow M, Newcomb EW. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg 1994;81:427-436.
32. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H. Overexpression of the EGFR receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-224.